House Speaker Kevin McCarthy says he “didn’t see any new movement” toward ending Washington’s standoff over the debt ceiling.
Washington Watch: Debt-ceiling solution? The 14th Amendment, explained.
Key questions and answers about the 14th Amendment to the U.S. Constitution and how it relates to the debt-ceiling stalemate.
Commodities Corner: EIA forecasts second-highest U.S. summer power demand on record for natural gas
The Energy Information Administration on Tuesday said it expects natural-gas demand to generate U.S. electricity this summer to reach its second-highest level on record. Separately, the government agency sharply reduced its 2023 and 2024 forecasts for U.S. and global oil prices.
Earnings Results: Plug Power stock tanks nearly 14% as earnings bring liquidity concerns
Shares of Plug Power were falling in Tuesday trading after the fuel-cell company’s latest earnings report brought a decline in liquidity.
The Moneyist: ‘I feel used’: My partner stays with me 5 nights a week, even though he owns his own home. Should he pay for utilities and food?
‘He accused me of being materialistic.’
: PacWest’s stock finds its footing, rising in the absence of negative updates on banks
PacWest’s stock reverses course and moves higher after losing ground earlier in the session, while banks overall ended mixed, with no major company updates.
: More than 192,000 tech-sector employees have lost their jobs since the start of 2023
LinkedIn is the latest tech company to announce layoffs.
: Skyworks Solutions stock falls following weak outlook
Skyworks Solutions Inc. shares fell Tuesday after the analog and mixed-signal chip maker’s outlook fell short of Wall Street expectations.
Earnings Results: Nikola’s stock turns lower after revenue miss and production pause to refocus on hydrogen-fuel-cell trucks
Nikola’s stock dropped Tuesday after the EV maker missed revenue expectations and said it was refocusing its business on hydrogen-fuel-cell trucks.
: Birth-control pills with no prescription? 4 things you need to know as FDA weighs over-the-counter approval.
Questions about cost and safety emerge as FDA considers the first daily oral contraceptive for nonprescription use.
- « Previous Page
- 1
- …
- 685
- 686
- 687
- 688
- 689
- …
- 1275
- Next Page »